Forensic Toxicologist Discovers Trace Biomarkers Uncovering Hidden Poisoning Case

The moment

In early March 2024, a middle-aged individual was found deceased in their Amsterdam residence under circumstances that initially defied explanation. The body was discovered during a routine welfare check after concerned relatives reported not hearing from the person for several days. The scene showed no obvious signs of trauma or struggle; the room appeared undisturbed, and no immediate clues pointed to natural causes or accidental death.

The forensic team collected biological samples—blood, urine, and tissue—according to standard protocols. Initial toxicology screens, including immunoassays and broad-spectrum GC-MS (gas chromatography-mass spectrometry), yielded no conclusive results. The absence of typical toxins or drugs left investigators questioning whether an unusual or novel substance might be involved, potentially requiring more sophisticated analysis. As the investigation stalled at this preliminary stage, the need for expert forensic toxicology support became apparent to unravel the mystery of the death.

Why years of experience made the difference

Johanna López had been part of the Amsterdam Forensic Institute's toxicology unit for over a decade, specialising in advanced analytical techniques and interpretation of complex chemical data. Her extensive experience in forensic analytical chemistry meant she was familiar not only with standard toxicological screens but also with the subtleties of trace biomarkers—chemical signatures found at levels often below routine detection limits.

Her background included working on cases involving rare neurotoxins, some of which are unstable, metabolise rapidly, or produce biomarkers that are difficult to detect without targeted, high-sensitivity methods. Over the years, Johanna developed an intuitive understanding of how different toxins fragment during mass spectrometry, recognising patterns that more automated or less experienced analysts might overlook. She was also well-versed in maintaining and calibrating high-resolution instruments, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can detect and quantify substances at parts-per-trillion levels.

This depth of expertise allowed Johanna to approach this ambiguous case with a nuanced perspective: knowing which biomarkers to look for, how to optimise the detection parameters, and how to interpret low-level signals within a broader toxicological context. Her familiarity with rare toxin profiles and her ability to distinguish genuine biomarkers from background noise proved critical in identifying substances that standard screens missed.

What happened next

Johanna began by performing targeted LC-MS/MS analysis on the blood sample, focusing on neurotoxic biomarkers associated with known, albeit uncommon, poisons. She employed a high-resolution orbitrap mass spectrometer, which provided precise mass measurements, enabling her to differentiate compounds with very similar structures. Her method involved extracting the sample with solid-phase extraction, followed by chromatographic separation tailored to isolate neurotoxic metabolites, then analysing the eluate with tandem mass spectrometry to detect specific fragmentation patterns.

She compared the detected signals to an extensive forensic toxicology database, which included reference spectra for a broad range of substances—common drugs, pesticides, industrial chemicals, and known neurotoxins. While routine screening had shown no significant findings, her analysis revealed trace-level biomarkers with a mass-to-charge ratio and fragmentation pattern consistent with a rare neurotoxicant: a specific alkaloid derivative linked to neurotoxicity and documented in only a handful of forensic cases globally.

Recognising the significance, Johanna collaborated with investigators to interpret her findings in context. She examined potential sources, considering whether this neurotoxicant could have been introduced deliberately or accidentally. The detection of low but definitive biomarkers pointed to recent exposure rather than post-mortem redistribution or environmental contamination. Her interpretation suggested that the victim’s death resulted from poisoning rather than natural causes.

This insight prompted further investigation, leading authorities to uncover evidence of clandestine activity involving the procurement of the neurotoxicant. The case ultimately culminated in the arrest of a suspect involved in orchestrating the poisoning, and the findings provided the critical evidence needed to support a criminal charge.

What this tells us

This case underscores how deep specialised knowledge and advanced analytical techniques in forensic toxicology are essential for uncovering hidden causes of death. Detecting trace biomarkers of uncommon substances requires not only sophisticated instrumentation but also the experience to interpret complex data accurately. Such expertise can distinguish between natural and unnatural causes, prevent wrongful suspicion, and contribute decisively to criminal investigations. In forensic science, precision and interpretive skill are often what stand between ambiguity and clarity, ultimately saving lives by ensuring justice is accurately served.